Prevalence and significance of Hepatitis B reverse transcriptase mutants in different disease stages of untreated patients (Q36295816)

13 August 2017

Prevalence and significance of Hepatitis B reverse transcriptase mutants in different disease stages of untreated patients (English)

1 reference

13 August 2017

Jinxin Zheng

1

1 reference

13 August 2017

Zheng Zeng

2

1 reference

13 August 2017

Duyi Zhang

3

1 reference

13 August 2017

Yanyan Yu

4

1 reference

13 August 2017

Fang Wang

5

1 reference

13 August 2017

Calvin Q Pan

6

1 reference

13 August 2017

13 August 2012

1 reference

13 August 2017

1 reference

13 August 2017

32

1 reference

13 August 2017

10

1 reference

13 August 2017

1535-1542

1 reference

Chronic hepatitis B: update 2009

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463715

Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463715

Chronic hepatitis B: early viral suppression and long-term outcomes of therapy with oral nucleos(t)ides

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463715

A population-based study to investigate host genetic factors associated with hepatitis B infection and pathogenesis in the Chinese population

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463715

Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463715

MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) Software Version 4.0

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463715

Detection of YMDD mutation using mutant-specific primers in chronic hepatitis B patients before and after lamivudine treatment

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463715

Mutations affecting the replication capacity of the hepatitis B virus

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463715

Cellular and virological mechanisms of HBV drug resistance

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463715

YMDD mutations in patients with chronic hepatitis B untreated with antiviral medicines

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463715

Detection of YMDD motif mutants by oligonucleotide chips in lamivudine-untreated patients with chronic hepatitis B virus infection

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463715

Clinical trial results and treatment resistance with lamivudine in hepatitis B.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463715

Comparisons of the HBV and HIV polymerase, and antiviral resistance mutations

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463715

Global control of hepatitis B virus infection.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463715

Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463715

Characterization of hepatitis B virus reverse transcriptase sequences in Chinese treatment naive patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463715

YMDD motif variants in inactive hepatitis B carriers detected by Inno-Lipa HBV DR assay.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463715

Hepatitis B virus genetic diversity

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463715

YMDD mutants in patients with chronic hepatitis B before treatment are not selected by lamivudine

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463715

Resistance surveillance in chronic hepatitis B patients treated with adefovir dipivoxil for up to 60 weeks

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463715

Detection of YMDD mutant using a novel sensitive method in chronic liver disease type B patients before and during lamivudine treatment

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463715

Detection of YMDD motif mutations in some lamivudine-untreated asymptomatic hepatitis B virus carriers

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463715

Prevalence and significance of naturally occurring mutations in the surface and polymerase genes of hepatitis B virus

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463715

Characterization of potential antiviral resistance mutations in hepatitis B virus reverse transcriptase sequences in treatment-naïve Chinese patients

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463715

From hepatitis to hepatoma: lessons from type B viral hepatitis

21 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22882650

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Entecavir resistance is rare in nucleoside naïve patients with hepatitis B

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22882650

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Pooled analysis of amino acid changes in the HBV polymerase in patients from four major adefovir dipivoxil clinical trials

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22882650

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1478-3231.2012.02859.X

1 reference

13 August 2017

1 reference

13 August 2017

PubMed publication ID

22882650

1 reference